Literature DB >> 23112757

High Intellectual Function in Individuals with Mutation-Positive Microform Holoprosencephaly.

B D Solomon1, D E Pineda-Alvarez, A L Gropman, M J Willis, D W Hadley, M Muenke.   

Abstract

Holoprosencephaly is the most common malformation of the forebrain and typically results in severe neurocognitive impairment with accompanying midline facial anomalies. Holoprosencephaly is heterogeneous and may be caused by chromosome aberrations or environmental factors, occur in the context of a syndrome or be due to heterozygous mutations in over 10 identified genes. The presence of these mutations may result in an extremely wide spectrum of severity, ranging from brain malformations incompatible with life to individuals with normal brain findings and subtle midline facial differences. Typically, clinicians regard intellectual disability as a sign that a parent or relative of a severely affected patient may be a mildly affected mutation 'carrier' with what is termed microform holoprosencephaly. Here we present 5 patients with clear phenotypic signs of microform holoprosencephaly, all of whom have evidence of above-average intellectual function. In 4 of these 5 individuals, the molecular cause of holoprosencephaly has been identified and includes mutations affecting SHH, SIX3, GLI2, and FGF8. This report expands the phenotypic spectrum of holoprosencephaly and is important in the counseling of patient and affected families.

Entities:  

Year:  2012        PMID: 23112757      PMCID: PMC3473351          DOI: 10.1159/000341373

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  9 in total

1.  A Hypomorphic Allele in the FGF8 Gene Contributes to Holoprosencephaly and Is Allelic to Gonadotropin-Releasing Hormone Deficiency in Humans.

Authors:  R F Arauz; B D Solomon; D E Pineda-Alvarez; A L Gropman; J A Parsons; E Roessler; M Muenke
Journal:  Mol Syndromol       Date:  2010-04-22

2.  New findings for phenotype-genotype correlations in a large European series of holoprosencephaly cases.

Authors:  Sandra Mercier; Christèle Dubourg; Nicolas Garcelon; Boris Campillo-Gimenez; Isabelle Gicquel; Marion Belleguic; Leslie Ratié; Laurent Pasquier; Philippe Loget; Claude Bendavid; Sylvie Jaillard; Lucie Rochard; Chloé Quélin; Valérie Dupé; Véronique David; Sylvie Odent
Journal:  J Med Genet       Date:  2011-09-22       Impact factor: 6.318

Review 3.  Holoprosencephaly: clinical, anatomic, and molecular dimensions.

Authors:  M Michael Cohen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-09

4.  The mutational spectrum of holoprosencephaly-associated changes within the SHH gene in humans predicts loss-of-function through either key structural alterations of the ligand or its altered synthesis.

Authors:  Erich Roessler; Kenia B El-Jaick; Christèle Dubourg; Jorge I Vélez; Benjamin D Solomon; Daniel E Pineda-Alvarez; Felicitas Lacbawan; Nan Zhou; Maia Ouspenskaia; Aimée Paulussen; Hubert J Smeets; Ute Hehr; Claude Bendavid; Sherri Bale; Sylvie Odent; Véronique David; Maximilian Muenke
Journal:  Hum Mutat       Date:  2009-10       Impact factor: 4.878

5.  A novel SIX3 mutation segregates with holoprosencephaly in a large family.

Authors:  Benjamin D Solomon; Felicitas Lacbawan; Mahim Jain; Sabina Domené; Erich Roessler; Cynthia Moore; William B Dobyns; Maximilian Muenke
Journal:  Am J Med Genet A       Date:  2009-05       Impact factor: 2.802

6.  Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function.

Authors:  F Lacbawan; B D Solomon; E Roessler; K El-Jaick; S Domené; J I Vélez; N Zhou; D Hadley; J Z Balog; R Long; A Fryer; W Smith; S Omar; S D McLean; K Clarkson; A Lichty; N J Clegg; M R Delgado; E Levey; E Stashinko; L Potocki; M I Vanallen; J Clayton-Smith; D Donnai; D W Bianchi; P B Juliusson; P R Njølstad; H G Brunner; J C Carey; U Hehr; J Müsebeck; P F Wieacker; A Postra; R C M Hennekam; M-J H van den Boogaard; A van Haeringen; A Paulussen; J Herbergs; C T R M Schrander-Stumpel; A R Janecke; D Chitayat; J Hahn; D M McDonald-McGinn; E H Zackai; W B Dobyns; M Muenke
Journal:  J Med Genet       Date:  2009-04-02       Impact factor: 6.318

Review 7.  Neuroimaging advances in holoprosencephaly: Refining the spectrum of the midline malformation.

Authors:  Jin S Hahn; Patrick D Barnes
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-02-15       Impact factor: 3.908

Review 8.  Analysis of genotype-phenotype correlations in human holoprosencephaly.

Authors:  Benjamin D Solomon; Sandra Mercier; Jorge I Vélez; Daniel E Pineda-Alvarez; Adrian Wyllie; Nan Zhou; Christèle Dubourg; Veronique David; Sylvie Odent; Erich Roessler; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-02-15       Impact factor: 3.908

Review 9.  The molecular genetics of holoprosencephaly.

Authors:  Erich Roessler; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-02-15       Impact factor: 3.908

  9 in total
  4 in total

Review 1.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

2.  Heterozygous mutation of sonic hedgehog receptor (Ptch1) drives cerebellar overgrowth and sex-specifically alters hippocampal and cortical layer structure, activity, and social behavior in female mice.

Authors:  Thomas W Jackson; Gabriel A Bendfeldt; Kelby A Beam; Kylie D Rock; Scott M Belcher
Journal:  Neurotoxicol Teratol       Date:  2020-02-27       Impact factor: 3.763

3.  Mutations in phospholipase C eta-1 (PLCH1) are associated with holoprosencephaly.

Authors:  Ichrak Drissi; Emily Fletcher; Ranad Shaheen; Michael Nahorski; Amal M Alhashem; Steve Lisgo; Alberto Fernández-Jaén; Katherine Schon; Kalthoum Tlili-Graiess; Sarah F Smithson; Susan Lindsay; Hayley J Sharpe; Fowzan S Alkuraya; Geoff Woods
Journal:  J Med Genet       Date:  2021-04-05       Impact factor: 6.318

4.  Boc modifies the spectrum of holoprosencephaly in the absence of Gas1 function.

Authors:  Maisa Seppala; Guilherme M Xavier; Chen-Ming Fan; Martyn T Cobourne
Journal:  Biol Open       Date:  2014-07-25       Impact factor: 2.422

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.